{"entity":{"type":"insider","cik":"0001643085","url":"/insider/0001643085","json_url":"/insider/0001643085.json","name":"GANNON STEVEN","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":8,"first":"2017-08-14","last":"2026-08-13","span_basis":"filed_date"},"name_variants":[{"name":"GANNON STEVEN","source":"filing","n_filings":8,"first_seen":"2017-08-14","last_seen":"2026-08-13"}],"transactions":[{"id":9255570,"accession":"0001193125-26-349351","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-349351","line_url":"/filing/0001193125-26-349351#line-1","is_derivative":false,"issuer_cik":"0001582313","issuer_name":"Xenon Pharmaceuticals Inc.","issuer_ticker":"XENE","issuer_name_source":null,"issuer_url":"/issuer/0001582313","owner_cik":"0001643085","owner_name":"GANNON STEVEN","owner_display_name":"GANNON STEVEN","owner_url":"/insider/0001643085","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":64.055,"price_display":"64.06","price_state":"stated","total_value":640550.0,"total_display":"640,550.00","total_whole":"640,550","shares_owned_after":1870.0,"shares_owned_after_display":"1,870","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-11","filed_date":"2026-08-13","scope":"insider"},{"id":4584443,"accession":"0000950170-25-083321","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-083321","line_url":"/filing/0000950170-25-083321#line-1","is_derivative":false,"issuer_cik":"0001582313","issuer_name":"Xenon Pharmaceuticals Inc.","issuer_ticker":"XENE","issuer_name_source":null,"issuer_url":"/issuer/0001582313","owner_cik":"0001643085","owner_name":"GANNON STEVEN","owner_display_name":"GANNON STEVEN","owner_url":"/insider/0001643085","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3.0,"shares_display":"3","price_per_share":30.48,"price_display":"30.48","price_state":"stated","total_value":91.44,"total_display":"91.44","total_whole":"91","shares_owned_after":7141.0,"shares_owned_after_display":"7,141","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-05","filed_date":"2025-06-06","scope":"insider"},{"id":2387281,"accession":"0000950170-24-028788","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-24-028788","line_url":"/filing/0000950170-24-028788","is_derivative":false,"issuer_cik":"0001582313","issuer_name":"Xenon Pharmaceuticals Inc.","issuer_ticker":"XENE","issuer_name_source":null,"issuer_url":"/issuer/0001582313","owner_cik":"0001643085","owner_name":"GANNON STEVEN","owner_display_name":"GANNON STEVEN","owner_url":"/insider/0001643085","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13000.0,"shares_display":"13,000","price_per_share":46.27806923076923,"price_display":"46.28","price_state":"stated","total_value":601614.9,"total_display":"601,614.90","total_whole":"601,615","shares_owned_after":4000.0,"shares_owned_after_display":"4,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-07","filed_date":"2024-03-08","scope":"insider","n_lines":4},{"id":6729367,"accession":"0001209191-22-045421","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-045421","line_url":"/filing/0001209191-22-045421#line-1","is_derivative":false,"issuer_cik":"0001643085","issuer_name":"Fusion Pharmaceuticals Inc.","issuer_ticker":"FUSN","issuer_name_source":null,"issuer_url":"/issuer/0001643085","owner_cik":"0001643085","owner_name":"GANNON STEVEN","owner_display_name":"GANNON STEVEN","owner_url":"/insider/0001643085","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":44400.0,"shares_display":"44,400","price_per_share":2.03,"price_display":"2.03","price_state":"stated","total_value":90132.0,"total_display":"90,132.00","total_whole":"90,132","shares_owned_after":56400.0,"shares_owned_after_display":"56,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-11","filed_date":"2022-08-11","scope":"insider"},{"id":5381548,"accession":"0001209191-21-053000","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-053000","line_url":"/filing/0001209191-21-053000#line-1","is_derivative":false,"issuer_cik":"0001643085","issuer_name":"Fusion Pharmaceuticals Inc.","issuer_ticker":"FUSN","issuer_name_source":null,"issuer_url":"/issuer/0001643085","owner_cik":"0001643085","owner_name":"GANNON STEVEN","owner_display_name":"GANNON STEVEN","owner_url":"/insider/0001643085","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2829.0,"shares_display":"2,829","price_per_share":7.985,"price_display":"7.98","price_state":"stated","total_value":22589.565,"total_display":"22,589.56","total_whole":"22,590","shares_owned_after":12000.0,"shares_owned_after_display":"12,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-23","filed_date":"2021-08-23","scope":"insider"},{"id":5087893,"accession":"0000899243-21-033814","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-033814","line_url":"/filing/0000899243-21-033814#line-2","is_derivative":false,"issuer_cik":"0001643085","issuer_name":"Fusion Pharmaceuticals Inc.","issuer_ticker":"FUSN","issuer_name_source":null,"issuer_url":"/issuer/0001643085","owner_cik":"0001643085","owner_name":"GANNON STEVEN","owner_display_name":"GANNON STEVEN","owner_url":"/insider/0001643085","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":8.05,"price_display":"8.05","price_state":"stated","total_value":24150.0,"total_display":"24,150.00","total_whole":"24,150","shares_owned_after":9171.0,"shares_owned_after_display":"9,171","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-19","filed_date":"2021-08-20","scope":"insider"},{"id":5087892,"accession":"0000899243-21-033814","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-033814","line_url":"/filing/0000899243-21-033814#line-1","is_derivative":false,"issuer_cik":"0001643085","issuer_name":"Fusion Pharmaceuticals Inc.","issuer_ticker":"FUSN","issuer_name_source":null,"issuer_url":"/issuer/0001643085","owner_cik":"0001643085","owner_name":"GANNON STEVEN","owner_display_name":"GANNON STEVEN","owner_url":"/insider/0001643085","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":171.0,"shares_display":"171","price_per_share":8.05,"price_display":"8.05","price_state":"stated","total_value":1376.55,"total_display":"1,376.55","total_whole":"1,377","shares_owned_after":6171.0,"shares_owned_after_display":"6,171","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-18","filed_date":"2021-08-20","scope":"insider"},{"id":5364359,"accession":"0000899243-21-033258","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-033258","line_url":"/filing/0000899243-21-033258#line-1","is_derivative":false,"issuer_cik":"0001643085","issuer_name":"Fusion Pharmaceuticals Inc.","issuer_ticker":"FUSN","issuer_name_source":null,"issuer_url":"/issuer/0001643085","owner_cik":"0001643085","owner_name":"GANNON STEVEN","owner_display_name":"GANNON STEVEN","owner_url":"/insider/0001643085","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":8.1,"price_display":"8.10","price_state":"stated","total_value":48600.0,"total_display":"48,600.00","total_whole":"48,600","shares_owned_after":6000.0,"shares_owned_after_display":"6,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-16","filed_date":"2021-08-17","scope":"insider"},{"id":4950233,"accession":"0001171843-17-005067","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001171843-17-005067","line_url":"/filing/0001171843-17-005067#line-1","is_derivative":false,"issuer_cik":"0001582313","issuer_name":"Xenon Pharmaceuticals Inc.","issuer_ticker":"XENE","issuer_name_source":null,"issuer_url":"/issuer/0001582313","owner_cik":"0001643085","owner_name":"GANNON STEVEN","owner_display_name":"GANNON STEVEN","owner_url":"/insider/0001643085","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":2.8178,"price_display":"2.82","price_state":"stated","total_value":42267.0,"total_display":"42,267.00","total_whole":"42,267","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-11","filed_date":"2017-08-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001582313","name":"Xenon Pharmaceuticals Inc.","url":"/issuer/0001582313","role":"Director","n_filings":4,"first_seen":"2017-08-14","last_seen":"2026-08-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001805890","name":"Fusion Pharmaceuticals Inc.","url":"/issuer/0001805890","role":"Director","n_filings":4,"first_seen":"2021-08-17","last_seen":"2022-08-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001643085","retrieved_at":"2026-08-23T13:48:39+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}